{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:46:38Z","timestamp":1780339598602,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Fundaci\u00f3n Espa\u00f1ola para el Estudio y Terap\u00e9utica de la Enfermedad de Gaucher y Otras Lisosomales"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.atherosclerosis.2019.03.013","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T11:57:23Z","timestamp":1552910243000},"page":"49-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Evaluation of two approaches to lysosomal acid lipase deficiency patient identification: An observational retrospective study"],"prefix":"10.1016","volume":"285","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8727-9179","authenticated-orcid":false,"given":"Jorge J.","family":"Cebolla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Ir\u00fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Mozas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Giraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib1","series-title":"Metab. Mol. Bases Inherit. Dis., eighth ed","article-title":"Lysosomal acid lipase deficiencies: the wolman disease\/cholesteryl ester storage disease spectrum","author":"Grabowski","year":"2012"},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib2","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/hep.26327","article-title":"Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G > A) in various racial and ethnic groups","volume":"58","author":"Scott","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib3","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jhep.2013.02.014","article-title":"Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease","volume":"58","author":"Bernstein","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib4","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/ATVBAHA.107.146639","article-title":"Prevalence of cholesteryl ester storage disease","volume":"27","author":"Muntoni","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib5","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1161\/ATVBAHA.113.302426","article-title":"Exome sequencing and directed clinical phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia","volume":"33","author":"Stitziel","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib6","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/jclinpath-2012-201302","article-title":"Cholesteryl ester storage disease: a rare and possibly treatable cause of premature vascular disease and cirrhosis","volume":"66","author":"Reynolds","year":"2013","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2014.04.003","article-title":"Lysosomal acid lipase deficiency - an under-recognized cause of dyslipidaemia and liver dysfunction","volume":"235","author":"Reiner","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0002-9440(10)65283-2","article-title":"Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques","volume":"154","author":"Reape","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.bpg.2010.09.001","article-title":"Lysosomal storage diseases as differential diagnosis of hepatosplenomegaly","volume":"24","author":"vom Dahl","year":"2010","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ymgme.2016.11.002","article-title":"Lysosomal acid lipase deficiency: expanding differential diagnosis","volume":"120","author":"Valayannopoulos","year":"2017","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib11","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1161\/01.ATV.0000089329.09061.07","article-title":"Serum chitotriosidase activity is increased in subjects with atherosclerosis disease","volume":"23","author":"Artieda","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1023\/B:BOLI.0000043025.17721.fc","article-title":"The expanding spectrum of disorders with elevated plasma chitotriosidase activity: an update","volume":"27","author":"Michelakakis","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cca.2007.07.019","article-title":"Plasma chitotriosidase in lysosomal storage diseases","volume":"387","author":"Isman","year":"2008","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib14","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1515\/jpem-2013-0365","article-title":"Chitotriosidase as a possible marker of clinically evidenced atherosclerosis in dyslipidemic children","volume":"27","author":"Kologlu","year":"2014","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib15","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.clinbiochem.2013.09.006","article-title":"Chitotriosidase variants in patients with Gaucher disease. Implications for diagnosis and therapeutic monitoring","volume":"46","author":"Ir\u00fan","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease\u202f: a novel surrogate marker for assessing therapeutic intervention","volume":"103","author":"Boot","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10545-005-4416-9","article-title":"Plasma chitotriosidase and CCL18: early biochemical surrogate markers in type B Niemann-Pick disease","volume":"28","author":"Brinkman","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2008.10.010","article-title":"Expression of chemokine (C-C motif) ligand 18 in human macrophages and atherosclerotic plaques","volume":"204","author":"H\u00e4gg","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12967-017-1146-3","article-title":"Assessment of plasma chitotriosidase activity, CCL18\/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: a prospective observational study","volume":"15","author":"De Castro-Or\u00f3s","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.medcli.2016.12.044","article-title":"Actualizaci\u00f3n en deficiencia de lipasa \u00e1cida lisosomal: diagn\u00f3stico, tratamiento y seguimiento de los pacientes","volume":"148","author":"Camarena","year":"2017","journal-title":"Med. Clin. (Barc)."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib21","doi-asserted-by":"crossref","DOI":"10.1373\/clinchem.2004.045203","article-title":"Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia","volume":"51","author":"Tejedor","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.2890","article-title":"MutationTaster2: mutation prediction for the deep-sequencing age","volume":"11","author":"Schwarz","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/humu.22225","article-title":"Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models","volume":"34","author":"Shihab","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/bioinformatics\/18.2.333","article-title":"PROMO: detection of known transcription regulatory elements using species-tailored searches","volume":"18","author":"Messeguer","year":"2002","journal-title":"Bioinformatics"},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib25","author":"R Core Team"},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib26","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cca.2012.03.019","article-title":"Clinica Chimica Acta A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2","volume":"413","author":"Hamilton","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2017.05.027","article-title":"Best practice in the measurement and interpretation of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2","author":"Lukacs","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib28","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/hep.26289","article-title":"Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease","volume":"58","author":"Balwani","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib29","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1501365","article-title":"A phase 3 trial of sebelipase alfa in lysosomal acid lipase deficiency","volume":"373","author":"Burton","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib30","first-page":"S59","article-title":"Effect of sebelipase alfa on survival and liver function in infants with rapidly progressive lysosomal acid lipase deficiency","volume":"114","author":"Jones","year":"2015","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib31","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jacl.2015.07.008","article-title":"Identification and metabolic profiling of patients with lysosomal acid lipase deficiency","volume":"9","author":"Pullinger","year":"2015","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.atherosclerosis.2016.07.008","article-title":"Sequencing for LIPA mutations in patients with a clinical diagnosis of familial hypercholesterolemia","volume":"251","author":"Sjouke","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jacl.2016.11.002","article-title":"Lysosomal acid lipase deficiency: a hidden disease among cohorts of familial hypercholesterolemia?","volume":"11","author":"Chora","year":"2017","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib34","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1194\/jlr.M060343","article-title":"Cholestane-3\u03b2,5\u03b1,6\u03b2-triol in lipidosis: high levels in Niemann pick type C, cerebrotendinous xanthomatosis and lysosomal acid lipase deficiency","volume":"56","author":"Pajares","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1194\/jlr.M061978","article-title":"Evaluation of plasma cholestane-3\u03b2,5\u03b1,6\u03b2-triol and 7-ketocholesterol in inherited disorders related to cholesterol metabolism","volume":"57","author":"Boenzi","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib36","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbrc.2013.12.087","article-title":"Preanalytical standardization for reactive oxygen species derived oxysterol analysis in human plasma by liquid chromatography-tandem mass spectrometry","volume":"446","author":"Helmschrodt","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0378-1119(99)00357-1","article-title":"The Sp-family of transcription factors","volume":"238","author":"Suske","year":"1999","journal-title":"Gene"},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib38","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOL.0b013e328361f6c6","article-title":"Lysosomal acid lipase A and the hypercholesterolaemic phenotype","volume":"24","author":"Fouchier","year":"2013","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2019.03.013_bib39","first-page":"1","article-title":"Recent advances in genetic testing for familial hypercholesterolemia","author":"Iacocca","year":"2017","journal-title":"Expert Rev. Mol. Diagn."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501930142X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501930142X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:38:11Z","timestamp":1758155891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191501930142X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":39,"alternative-id":["S002191501930142X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.03.013","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of two approaches to lysosomal acid lipase deficiency patient identification: An observational retrospective study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}